BIO FY 2007 Earnings Report — Bio-Rad Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

Bio-Rad Laboratories, Inc.BIO

FY 2007 Earnings

Reported February 29, 2008

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$1.5B	—	$1.3B	—	14.7%
Op. Income	$135M	—	$146M	—	-7.5%
Gross Margin	54.2%	—	55.9%	—	-1.8pp
Net Margin	6.4%	—	8.1%	—	-1.7pp
EPS (Diluted)	$3.41	—	$3.83	—	-11.0%
Free Cash Flow	$129M	—	$65M	—	97.6%

Revenue Flow

Item	Amount
REVENUE	$1.5B
Cost of Revenue	$670M
GROSS PROFIT	$791M
R&D Expenses	$141M
Selling & Marketing	$0
General & Administrative	$508M
SG&A Expenses	$508M
Other Expenses	$0
Operating Expenses	$649M
Cost & Expenses	$1.3B
OPERATING INCOME	$135M
Interest Income	$0
Interest Expense	$32M
Other Income/Expenses	-$14M
INCOME BEFORE TAX	$121M
Income Tax Expense	$27M
Net Income from Continuing Ops	$94M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$93M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$93M
D&A	$67M
EBIT	$152M
EBITDA	$220M
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$1.5B
Cost of Revenue	$670M
GROSS PROFIT	$791M
R&D Expenses	$141M
Selling & Marketing	$0
General & Administrative	$508M
SG&A Expenses	$508M
Other Expenses	$0
Operating Expenses	$649M
Cost & Expenses	$1.3B
OPERATING INCOME	$135M
Interest Income	$0
Interest Expense	$32M
Other Income/Expenses	-$14M
INCOME BEFORE TAX	$121M
Income Tax Expense	$27M
Net Income from Continuing Ops	$94M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$93M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$93M
D&A	$67M
EBIT	$152M
EBITDA	$220M
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$93M
Depreciation & Amortization	$67M
Stock-Based Compensation	$0
Deferred Income Tax	-$6M
Other Non-Cash Items	$26M
Change in Working Capital	$11M
OPERATING CASH FLOW	$192M
Capital Expenditure	-$63M
Acquisitions (Net)	-$388M
Purchases of Investments	-$270M
Sales/Maturities of Investments	$470M
Other Investing Activities	-$4M
NET CASH FROM INVESTING	-$254M
Net Debt Issuance	-$22M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$3M
NET CASH FROM FINANCING	-$7M
FREE CASH FLOW	$129M
Net Change in Cash	-$62M

Balance Sheet

Item	Amount
Cash & Equivalents	$162M
Short-Term Investments	$62M
Net Receivables	$358M
Inventory	$321M
Other Current Assets	$36M
TOTAL CURRENT ASSETS	$1.0B
PP&E (Net)	$272M
Goodwill	$328M
Intangible Assets	$210M
Long-Term Investments	$0
Tax Assets	$20M
Other Non-Current Assets	$112M
TOTAL NON-CURRENT ASSETS	$943M
TOTAL ASSETS	$2.0B
Account Payables	$96M
Short-Term Debt	$16M
Deferred Revenue	$0
Other Current Liabilities	$230M
TOTAL CURRENT LIABILITIES	$414M
Long-Term Debt	$442M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$51M
Other Non-Current Liabilities	$93M
TOTAL NON-CURRENT LIABILITIES	$586M
TOTAL LIABILITIES	$1000M
Common Stock	$3.0K
Additional Paid-In Capital	$99M
Retained Earnings	$762M
Treasury Stock	$0
Accum. Other Comp. Income	$111M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$972M
Minority Interest	$0
TOTAL EQUITY	$972M
TOTAL LIABILITIES & EQUITY	$2.0B
Total Debt	$457M
Net Debt	$296M